Post by
Noteable on Jan 31, 2023 8:18pm
ONCY IND-213 -> AWARE-1-> BRACELET-1
Focus on this instead of that ! Focus on pelareorep in combination with other I/O agents rather than pelareorep as a monotherapy as was trialed in the H & N study, which also didn't understand that pelareorep causes mild flu like symptoms that are favorable and of little concern.
Comment by
Noteable on Jan 31, 2023 8:23pm
Furthermore 'precision medicine' involves treating subgroups of patients - which is why Merck has received 5 different FDA approvals for a single type of cancer, namely NSCLC. I suggest you see the positives in this development rather than jumping into your world of negatives.
Comment by
Noteable on Jan 31, 2023 8:28pm
Should read " ...which is why Merck has received 5 different FDA approvals for Keytruda in a single type of cancer, namely NSCLC."